About Ronak Exim
Ronak Exim is a Consumer company. Pharmaceutical manufacturing, exporting, and distribution in India. It operates in the Consumer and Healthcare sectors. The company has 46 employees. Its Indian entity Ronak Exim Private Ltd reported revenue of ₹223 Cr. Ronak Exim offers products and services including Pharmaceutical Formulations and Health Supplements. Its focus areas include Personal Care, Cosmetics and Supplements, Herbal Products and Pharmaceuticals.
Company details
Ronak Exim is recognized as a leading pharmaceutical company in India that has been engaged in manufacturing and exporting pharmaceuticals, health supplements, cosmetics, and herbal formulations since 2006. Its products, audited by agencies like WHO-GMP, are distributed across Africa, South, and East Asia. A commitment to ethical practices and affordable rates ensures these formulations are made accessible worldwide, with over 500 products marketed under its brand. Quality is maintained through adherence to international standards, innovative designs, and timely delivery to meet market needs.
- Employees 46
- SectorsConsumerHealthcare
- Email••••••••
- Phone•••• ••••
- Legal Name Ronak Exim Private Limited
- Date of Incorporation 05 Jul, 2006
- Jurisdiction Vadodara, Gujarat, India
- Indian entity revenue₹223 Cr
FY 2025 · +19% YoY
- Indian entity net profit₹6.63 Cr
FY 2025 · 3% margin
- Indian entity EBITDA₹9.56 Cr
FY 2025 · 4% margin
- Employee Count46
Associated legal entities of Ronak Exim
Ronak Exim operates through Ronak Exim Private Ltd (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ronak Exim Private Ltd CIN U51109GJ2006PTC048622 | Active | 05 Jul 2006 | Vadodara, Gujarat | ₹223 Cr | 46 | 4 | View details |
Products & Services of Ronak Exim
Ronak Exim offers a comprehensive portfolio of products and services, including Pharmaceutical Formulations and Health Supplements.
A diverse range of pharmaceutical products, such as injections and tablets, are processed using finest ingredients to maintain effectiveness and shelf life
Health supplements and herbal formulations are developed and exported by Ronak Exim to address nutritional needs in various regions
Board of directors of Ronak Exim Private Ltd (Ronak Exim)
Ronak Exim Private Ltd is the primary company behind Ronak Exim. The board of Ronak Exim Private Ltd currently have 4 directors; the longest-serving is Ronakali Saifuddin Dholkawala, appointed in 2006. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ronakali Saifuddin Dholkawala DIN 00277279 | Managing Director | 05 Jul 2006 | 20 yrs 3 mo | Ronak Exim Private Ltd |
| Nayabali Saifuddin Dholkawala DIN 02435920 | Whole-time director | 05 Jul 2006 | 20 yrs 3 mo | Ronak Exim Private Ltd |
| Ahmedali Saifuddin Dholkawala DIN 03178754 | Director | 26 Aug 2011 | 15 yrs 2 mo | Ronak Exim Private Ltd |
| Asgarali Saifuddin Dholkawala DIN 03178775 | Director | 26 Aug 2011 | 15 yrs 2 mo | Ronak Exim Private Ltd |
Financials of Ronak Exim
Figures of Ronak Exim Private Ltd, the primary company behind Ronak Exim, for FY 2025. Revenue was ₹223 Cr (+19% year on year). Net profit was ₹6.63 Cr (3% margin). EBITDA was ₹9.56 Cr (4% margin). Revenue has grown at a compounded annual rate of +6% over three years and +28% over five years.
- ₹223 CrRevenue · FY 2025 · +19% YoY
- ₹6.63 CrNet profit · 3% margin
- ₹9.56 CrEBITDA · 4% margin
- ₹25 LakhPaid-up capital
- 46Employees (provident fund records)
- +6%Revenue CAGR, 3 years
- +28%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Ronak Exim Private Ltd are on its company page.
Detailed financial statements for Ronak Exim
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Ronak Exim
Ronak Exim has 46 employees.
The primary company behind Ronak Exim, Ronak Exim Private Ltd, reported revenue of ₹223 Cr for FY 2025, up 19% year on year.
Ronak Exim is recognized as a leading pharmaceutical company in India that has been engaged in manufacturing and exporting pharmaceuticals, health supplements, cosmetics, and herbal formulations since 2006. Its products, audited by agencies like WHO-GMP, are distributed across Africa, South, and East Asia. A commitment to ethical practices and affordable rates ensures these formulations are made accessible worldwide, with over 500 products marketed under its brand. Quality is maintained through adherence to international standards, innovative designs, and timely delivery to meet market needs.
Ronak Exim offers Pharmaceutical Formulations and Health Supplements.
Ronak Exim operates through Ronak Exim Private Ltd.
The legal entities of Ronak Exim currently have 4 directors, including Ahmedali Saifuddin Dholkawala, Asgarali Saifuddin Dholkawala, Ronakali Saifuddin Dholkawala and others.